163 related articles for article (PubMed ID: 3150951)
1. In vitro activity of antimicrobial agents against mycobacteria.
Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R
Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951
[TBL] [Abstract][Full Text] [Related]
2. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
Sato K; Tomioka H
Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
[TBL] [Abstract][Full Text] [Related]
4. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
Tsukamura M
Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
[TBL] [Abstract][Full Text] [Related]
5. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
Tomioka H
Arch Immunol Ther Exp (Warsz); 2000; 48(3):183-8. PubMed ID: 10912623
[TBL] [Abstract][Full Text] [Related]
6. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
7. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
8. Massetolides A-H, antimycobacterial cyclic depsipeptides produced by two pseudomonads isolated from marine habitats.
Gerard J; Lloyd R; Barsby T; Haden P; Kelly MT; Andersen RJ
J Nat Prod; 1997 Mar; 60(3):223-9. PubMed ID: 9157190
[TBL] [Abstract][Full Text] [Related]
9. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA.
Dutta NK; Mazumdar K; Dastidar SG; Chakrabarty AN; Shirataki Y; Motohashi N
In Vivo; 2005; 19(3):539-45. PubMed ID: 15875773
[TBL] [Abstract][Full Text] [Related]
11. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex].
Yamamoto T; Amitani R; Kuze F; Suzuki K
Kekkaku; 1990 Dec; 65(12):805-10. PubMed ID: 2127615
[TBL] [Abstract][Full Text] [Related]
13. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
14. Clinical mycobacteriology. Drug susceptibility testing.
Heifets LB
Clin Lab Med; 1996 Sep; 16(3):641-56. PubMed ID: 8866184
[TBL] [Abstract][Full Text] [Related]
15. [Currently used laboratory methods for testing the sensitivity and resistance of mycobacteria to drugs. Usefulness and limitations (author's transl)].
Simon-Pouthier F
Acta Tuberc Pneumol Belg; 1972; 63(4):399-404. PubMed ID: 4206437
[No Abstract] [Full Text] [Related]
16. [A susceptibility study of Mycobacterium avium-intracellulare strains using the broth macrodilution method].
Mederos Cuervo LM; Ferrá Salazar C; Jimenez Misas CA; Valdivia Alvarez JA
Rev Cubana Med Trop; 1995; 47(1):54-8. PubMed ID: 9805069
[TBL] [Abstract][Full Text] [Related]
17. [Studies of the resistance of mycobacteria].
Savov N
Vet Med Nauki; 1973; 10(2):39-49. PubMed ID: 4213759
[No Abstract] [Full Text] [Related]
18. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
Lu T; Drlica K
J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
[TBL] [Abstract][Full Text] [Related]
19. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
